CVS Health Corp. has suspended sales of the popular heartburn drug Zantac, as well as its own generic, called ranitidine, following a Food and Drug Administration alert earlier this month that the medicine contained a possible carcinogen.
Ranitidine is a common stomach acid drug that's available over the counter and by prescription to people of all ages.
Walgreens said Monday it too was "removing Zantac and ranitidine products from our shelves while the FDA continues its review of the products,"
A division of the Swiss pharmaceutical company Novartis said it was halting worldwide distribution of ranitidine.
Canada's federal government has also asked companies to stop distributing ranitidine products.
No comments:
Post a Comment